Figure 2.
Figure 2. Kaplan-Meier analysis of OS, EFS, and DFS for de novo AML patients with normal cytogenetics. AML patients with high BAALC expression show significantly inferior OS (A), EFS (B), and DFS (C) compared to low BAALC patients.

Kaplan-Meier analysis of OS, EFS, and DFS for de novo AML patients with normal cytogenetics. AML patients with high BAALC expression show significantly inferior OS (A), EFS (B), and DFS (C) compared to low BAALC patients.

Close Modal

or Create an Account

Close Modal
Close Modal